Inflammatory markers and the risk of Alzheimer disease: The Framingham Study

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Cerebral amyloid angiopathy. A critical review.

Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070

Inflammatory mediators in the elderly

Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928

Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study

Rost, N. S., Wolf, P. A., Kase, C. S., Kelly‐Hayes, M., Silbershatz, H., Massaro, J. M., D’Agostino, R. B., Franzblau, C., & Wilson, P. W. F. (2001) · Stroke · doi:10.1161/hs1101.098151 · Cited by 806

Passage of cytokines across the blood–brain barrier

Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction

Vasan, R. S., SULLIVAN, L. M., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Sawyer, D. B., Levy, D. A., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 763

β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721

Inflammatory markers and cognition in well-functioning African-American and white elders

Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706

Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy

Kountouras, J. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.159046 · Cited by 46

Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs

Sood, A., & Raji, M. A. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05372-1 · Cited by 49

Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls

Cisbani, G., & Rivest, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01083-4 · Cited by 44

Peroxisome proliferator-activated receptor and age-related macular degeneration

Herzlich, A. A., Tuo, J., & Chan, C.-C. (2008) · PPAR Research · doi:10.1155/2008/389507 · Cited by 43

The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease.

Farhad, S. Z., Amini, S., Khalilian, A., Barekatain, M., Mafi, M., Barekatain, M., & Rafei, E. (2014) · Europe PMC (PubMed Central) · Cited by 44

Interleukin‐6, interleukin‐6 receptor gene variant, small‐vessel disease and incident dementia

Miwa, K., Okazaki, S., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2016) · European Journal of Neurology · doi:10.1111/ene.12921 · Cited by 43

Caffeic acid phenethyl ester (CAPE) prevents development of STZ-ICV induced dementia in rats

Bansal, N., Kumar, M., & Kaur, D. (2017) · Pharmacognosy Magazine · doi:10.4103/0973-1296.203974 · Cited by 44

Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction

Kumar, A., Ekavali, Mishra, J., Chopra, K., & Dhull, D. K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4095-7 · Cited by 44

Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases

Lindbohm, J. V., Mars, N., Sipilä, P. N., Singh‐Manoux, A., Runz, H., FinnGen, Livingston, G., Seshadri, S. S., Xavier, R. J., Hingorani, A. D., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00293-x · Cited by 42

Declines in inflammation predict greater white matter microstructure in older adults

Bettcher, B. M., Yaffe, K. S., Boudreau, R. M., Neuhaus, J. M., Aizenstein, H. J., Ding, J., Kritchevsky, S. B., Launer, L. J., Liu, Y., Satterfield, S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.004 · Cited by 43

The genetic pleiotropy of musculoskeletal aging

Karasik, D., & Cohen, M. W. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00303 · Cited by 41

The use of magnetic field for the reduction of inflammation: a review of the history and therapeutic results.

Ross, C. L., & Harrison, B. S. (2013) · PubMed · Cited by 41

Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease

Umemura, A., Oeda, T., Yamamoto, K., Tomita, S., Kohsaka, M., Park, K., Sugiyama, H., & Sawada, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136722 · Cited by 40

Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF- κ B Signaling in BV-2 Microglial Cells

Kwon, S., Ma, S., Hong, S., Lee, S., & Jang, C. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3341 · Cited by 40

The basis for disease‐modifying treatments for Alzheimer's disease: The Sixth Annual Mild Cognitive Impairment Symposium

Duara, R., Barker, W., Loewenstein, D., & Bain, L. J. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.10.006 · Cited by 39

Identification of inflammatory and vascular markers associated with mild cognitive impairment

Shen, X., Lu, Y., Tan, C. T. Y., Liu, L.-Y., Yu, J., Feng, L., & Larbi, A. (2019) · Aging · doi:10.18632/aging.101924 · Cited by 37

Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?

Tan, Z. S., & Seshadri, S. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt29 · Cited by 39

The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway

Gabin, J. M., Saltvedt, I. T., Tambs, K., & Holmen, J. (2018) · Immunity & Ageing · doi:10.1186/s12979-017-0106-3 · Cited by 39

Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias

Cai, H., Zhao, T., Pang, Y., Fu, X., Ren, Z., Quan, S., & Jia, L. (2024) · Brain · doi:10.1093/brain/awae230 · Cited by 42

Increased Plasma TACE Activity in Subjects with Mild Cognitive Impairment and Patients with Alzheimer's Disease

Sun, Q., Hampel, H. J., Blennow, K., Lista, S., Levey, A. I., Tang, B., Li, R., & Shen, Y. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140177 · Cited by 40

Early chronic systemic inflammation and associations with cognitive performance after moderate to severe TBI

Milleville, K. A., Awan, N., DiSanto, D., Kumar, R. G., & Wagner, A. K. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100185 · Cited by 39

Plasma Acetylcholinesterase Activity Correlates with Intracerebral β-Amyloid Load

Alkalay, A., Rabinovici, G. D., Zimmerman, G., Agarwal, N., Kaufer, D., Miller, B. L., Jagust, W. J., & Soreq, H. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310010007 · Cited by 38

Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated I B

Jiang, H. X., He, P., Xie, J., Staufenbiel, M., Li, R., & Shen, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu206 · Cited by 37

Gut-brain axis interplay via STAT3 pathway: Implications of Helicobacter pylori derived secretome on inflammation and Alzheimer’s disease

Kandpal, M., Baral, B., Varshney, N., Jain, A. K., Chatterji, D., Meena, A. K., Pandey, R. K., & Jha, H. C. (2024) · Virulence · doi:10.1080/21505594.2024.2303853 · Cited by 34

Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 36

Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer’s Disease Model

Shi, X., Ohta, Y., Liu, X., Shang, J., Morihara, R., Nakano, Y., Feng, T., Huang, Y. C., Sato, K., Takemoto, M., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181218 · Cited by 36

Inflammation is associated with future depressive symptoms among older adults

Bondy, E., Norton, S. A., Voss, M., Marks, R. B., Boudreaux, M. J., Treadway, M. T., Oltmanns, T. F., & Bogdan, R. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100226 · Cited by 35

Obstructive Sleep Apnea-hypopnea Syndrome as a Novel Potential Risk for Aging

Li, Y., & Wang, Y. (2021) · Aging and Disease · doi:10.14336/ad.2020.0723 · Cited by 37

Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 35

Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer’s Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis

Doroszkiewicz, J., Mroczko, J., Winkel, I., & Mroczko, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175057 · Cited by 36

(Putative) sex differences in neuroimmune modulation of memory

Tronson, N. C., & Collette, K. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23921 · Cited by 36

Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease

Tobinick, E. L. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015073 · Cited by 34

Spinal cord injury and Alzheimer’s disease risk: a population-based, retrospective cohort study

Yeh, T., Ho, Y., Hsu, C., & Pan, S. (2017) · Spinal Cord · doi:10.1038/s41393-017-0009-3 · Cited by 33

Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis

Trenova, A. G., Slavov, G. S., Draganova-Filipova, M., Mateva, N. G., Manova, M. G., Miteva, L. D., & Stanilova, S. A. (2018) · Neurological Research · doi:10.1080/01616412.2017.1420522 · Cited by 36

The relationship between inflammatory markers and voxel-based gray matter volumes in nondemented older adults

Zhang, H., Sachdev, P. S., Wen, W., Crawford, J. D., Brodaty, H., Baune, B. T., Kochan, N. A., Slavin, M. J., Reppermund, S., Kang, K., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.008 · Cited by 32

Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia

Cervellati, C., Trentini, A., Bosi, C., Valacchi, G., Morieri, M. L., Zurlo, A., Brombo, G., Passaro, A., & Zuliani, G. (2018) · GeroScience · doi:10.1007/s11357-018-0010-6 · Cited by 32

Cerebrospinal Fluid C-Reactive Protein in Parkinson’s Disease: Associations with Motor and Non-motor Symptoms

Moghaddam, H. S., valitabar, Z., Ashraf‐Ganjouei, A., Zadeh, M. M., Sherbaf, F. G., & Aarabi, M. H. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8499-5 · Cited by 32

The link between periodontitis and Alzheimer's disease – emerging clinical evidence

Wu, D. T. S., Cho, Y. W., Spalti, M. D., Bishara, M., & Nguyen, T. T. H. (2022) · Dentistry Review · doi:10.1016/j.dentre.2022.100062 · Cited by 38

Intracellular cytokine production and cognition in healthy older adults

Simpson, E. E. A., Hodkinson, C. F., Maylor, E. A., McCormack, J. M., Rae, G., Strain, J., Alexander, H. D., & Wallace, J. M. W. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.04.007 · Cited by 32

Innate Immunity and the Etiology of Late-Onset Alzheimer’s Disease

Eikelenboom, P., van Exel, E. R., Veerhuis, R., Rozemüller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334287 · Cited by 32

Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent Cerebrolysin

Alvarez, X. A., Sampedro, C., Cacabelos, R., Linares, C., Aleixandre, M., García-Fantini, M., & Moessler, H. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990101 · Cited by 32

Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment

Çölgeçen, E., Çelikbilek, A., & Keskin, D. T. (2016) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0187-3 · Cited by 33

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review

Thong, E. H., Quek, J. W. E., Loo, J. H., Yun, C.-Y., Teo, Y. N., Teo, Y. H., Leow, A. S., Li, T. Y., Sharma, V. K., Tan, B. Y., et al. (2023) · Biology · doi:10.3390/biology12081154 · Cited by 31

Genetic priming of a proinflammatory profile predicts low IQ in octogenarians

Krabbe, K. S., Mortensen, E. L., Avlund, K., Pilegaard, H., Christiansen, L., Pedersen, B. K., Schroll, M., Jørgensen, T., Pedersen, B. K., & Brüünsgaard, H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.013 · Cited by 33

Longitudinal Associations Between Serum Cytokine Levels and Dementia

Kim, J.-W., Stewart, R., Kang, H.-J., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Yoon, J.-S., & Kim, J.-M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00606 · Cited by 29

Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic*

Yen, H., Yen, H., & Chi, C. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19025 · Cited by 33

Association between chronic periodontitis and the risk of Alzheimer’s disease: combination of text mining and GEO dataset

Jiang, Z., Shi, Y., Zhao, W., Zhou, L., Zhang, B., Xie, Y., Zhang, Y., Tan, G., & Wang, Z. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01827-2 · Cited by 31

Inflammation and Hyaluronic Acid

Cooper, C. A., Brown, K., Meletis, C. D., & Zabriskie, N. (2008) · Alternative and Complementary Therapies · doi:10.1089/act.2008.14201 · Cited by 29

How Predictive of Dementia are Peripheral Inflammatory Markers in the elderly?

Metti, A. L., & Cauley, J. A. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.68 · Cited by 29

Biopsychosocial Factors and Cognitive Function in Cat Ownership and Attachment in Community-dwelling Older Adults

Branson, S., Boss, L., Padhye, N. S., Gee, N. R., & Trötscher, T. T. (2019) · Anthrozoös · doi:10.1080/08927936.2019.1569908 · Cited by 33

IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer’s disease mouse model

Lonnemann, N., Hosseini, S., Ohm, M., Geffers, R., Hiller, K., Dinarello, C. A., & Körte, M. (2021) · eLife · doi:10.7554/elife.75889 · Cited by 29

Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.

Tobinick, E. L. (2008) · PubMed · Cited by 28

Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?

Rommy von Bernhardi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1248 · Cited by 28

Biologic Commonalities between Mental Illness and Addiction.

Hartwell, K. J., Tolliver, B. K., & Brady, K. T. (2009) · PubMed · Cited by 28

Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2

Horowitz, R. I., & Freeman, P. (2018) · Healthcare · doi:10.3390/healthcare6040129 · Cited by 25

Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community Sample

Schmidt, M. F., Freeman, K. B., Windham, B. G., Griswold, M. E., Kullo, I. J., Turner, S. T., & Mosley, T. H. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14283 · Cited by 28

Circulating Cellular Adhesion Molecules and Cognitive Function: The Coronary Artery Risk Development in Young Adults Study

Yoon, C. Y., Steffen, L. M., Gross, M. D., Launer, L. J., Odegaard, A., Reiner, A. P., Sanchez, O. A., Yaffe, K. S., Sidney, S. S., & Jacobs, D. R. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00037 · Cited by 27

Risk Estimations, Risk Factors, and Genetic Variants Associated with Alzheimer's Disease in Selected Publications from the Framingham Heart Study

Weinstein, G., Wolf, P. A., Beiser, A., Au, R., & Seshadri, S. S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129040 · Cited by 29

Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease

Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Stella, F., & Gattaz, W. F. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-3505 · Cited by 31

Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran.

Ardebili, S. M. M., Yeghaneh, T., Gharesouran, J., Rezazadeh, M., Farhoudi, M., Ayromlou, H., Talebi, M., & Ghojazadeh, M. (2011) · PubMed Central · Cited by 27

Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease

Rasmuson, S., Näsman, B., & Olsson, T. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000810 · Cited by 27

A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults

Sanborn, V. E., Azcárate-Peril, M. A., Updegraff, J. A., Manderino, L. M., & Gunstad, J. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.11.006 · Cited by 27

Low-Grade systemic inflammation is associated with domain-specific cognitive performance and cognitive decline in older adults: Data from the TUDA study

Dyer, A. H., McNulty, H., Caffrey, A., Gordon, S., Laird, E. J., Hoey, L., Hughes, C., Ward, M., Strain, J., O’Kane, M., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.11.008 · Cited by 27

Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities

Myasoedova, E., Sattui, S. E., Lee, J., O'Brien, J. T., & Makris, U. E. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00190-5 · Cited by 29

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife

Cohen‐Manheim, I., Doniger, G. M., Sinnreich, R., Simon, E. S., Pinchas‐Mizrachi, R., Otvos, J. D., & Kark, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138036 · Cited by 27

The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials

Yaffe, K. S., Tocco, M., Petersen, R. C., Sigler, C., Burns, L. C., Cornelius, C., Khachaturian, A. S., Irizarry, M. C., & Carrillo, M. C. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.12.005 · Cited by 25

Central adiposity and the functional magnetic resonance imaging response to cognitive challenge

Gonzales, M. M., Kaur, S., Eagan, D. E., Goudarzi, K., Pasha, E. P., Doan, D. C., Tanaka, H., & Haley, A. P. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.5 · Cited by 25

Effects of Salvia officinalis L. and Chamaemelum nobile (L.) extracts on inflammatory responses in two models of human cells: Primary subcutaneous adipocytes and neuroblastoma cell line (SK-N-SH)

Russo, C. A., Edwards, K. D., Margetts, G., Kleidonas, S., Zaibi, N. S., Clapham, J. C., & Zaibi, M. S. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113614 · Cited by 24

Biomarkers of Parkinson’s Disease: From Basic Research to Clinical Practice

Ma, Z.-L., Wang, Z., Zhang, F., Liu, H. P., Mao, L.-H., & Yuan, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.1005 · Cited by 29

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond

Garmendia, J. V., Sanctis, C. V. D., Das, V., Annadurai, N., Hajdúch, M., & Sanctis, J. B. D. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231017141636 · Cited by 27

Peripheral immune function and Alzheimer’s disease: a living systematic review and critical appraisal

Li, C., Stebbins, R. C., Noppert, G. A., Carney, C. X., Liu, C., Sapp, A. R. M., Watson, E. J., & Aiello, A. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02355-x · Cited by 24

Inflammatory cytokine levels implicated in Alzheimer’s disease moderate the effects of sex on verbal memory performance

Caldwell, J., Kinney, J. W., Ritter, A. R., Salazar, A., Wong, C. G., Cordes, D., & Slavich, G. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.001 · Cited by 23

The metabolic and neuroinflammatory changes induced by consuming a cafeteria diet are age-dependent

Teixeira, D., Cecconello, A. L., Partata, W. A., de Fraga, L. S., Ribeiro, M. F. M., & Guedes, R. P. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1380892 · Cited by 25

Immune Profiling in Blood Identifies sTNF-R1 Performing Comparably Well as Biomarker Panels for Classification of Alzheimer's Disease Patients

Laske, C., Schmohl, M., Leyhe, T., Stransky, E., Maetzler, W., Berg, D., Fallgatter, A. J., Joos, T. O., & Dietzsch, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121558 · Cited by 23

Ellagic Acid Administration Negated the Development of Streptozotocin-Induced Memory Deficit in Rats

Bansal, N., Yadav, P., & Kumar, M. (2017) · Drug Research · doi:10.1055/s-0043-108552 · Cited by 22

Peripheral inflammation is a potential etiological factor in Alzheimer’s disease

Li, Z., Wang, H., & Yin, Y. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0049 · Cited by 23

Risk of dementia in survivors of active tuberculosis in Korea: A nationwide cohort study

Yeo, Y., Yoo, J. E., Han, K., Jung, J., Choi, H., Park, J., Shin, D. W., & Lee, H. J. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.12.006 · Cited by 22

Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches

Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 27

The "Alzheimer's disease signature": potential perspectives for novel biomarkers

Davinelli, S., Intrieri, M., Russo, C., Costanzo, A. D., Zella, D., Bosco, P., & Scapagnini, G. (2011) · Immunity & Ageing · doi:10.1186/1742-4933-8-7 · Cited by 22

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

dos Santos, R. R., Torres, K., Lima, G. S., Fiamoncini, C. M., Mapa, F. C., Pereira, P. A., de Rezende, V. B., Martins, L. C., Bicalho, M. A. C., de Moraes, E. N., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.019 · Cited by 21

Time-response studies on development of cognitive deficits in an experimental model of insulin resistance

Sachdeva, A. K., Dharavath, R. N., & Chopra, K. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.966 · Cited by 21

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease

Bu, X., Jiao, S., Lian, Y., & Wang, Y. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151215110114 · Cited by 20

Alzheimer's Disease

Mandell, A. M., & Green, R. C. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch1 · Cited by 22

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Bettinetti‐Luque, M., Trujillo‐Estrada, L., García‐Fuentes, E., Andreo‐Lopez, J., Sanchez-Varo, R. M., Garrido‐Sánchez, L., Mediavilla, A. G., López, M. G., García‐Caballero, M., Gutiérrez, A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16243 · Cited by 21

Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL‐1β) in Alzheimer's disease patients and intermediate levels in late‐onset depression patients

Torres, K., Lima, G. S., Fiamoncini, C. M., de Rezende, V. B., Pereira, P. A., Bicalho, M. A. C., de Moraes, E. N., & Romano‐Silva, M. A. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3973 · Cited by 20

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

Abraham, J.-D., Calvayrac-Pawlowski, S., Cobo, S., Salvetat, N., Vicat, G., Molina, L., Touchon, J., Michel, B., Molina, F., Verdier, J., et al. (2011) · Biomarkers · doi:10.3109/1354750x.2010.536995 · Cited by 20

Coronary artery disease in patients with dementia

Fowkes, R., Byrne, M. H. V., Sinclair, H., Tang, E. Y. H., & Kunadian, V. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000377 · Cited by 19

Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions

Nday, C. M., Eleftheriadou, D., & Jackson, G. E. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14256 · Cited by 21

γH2AX is increased in peripheral blood lymphocytes of Alzheimer’s disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging

Siddiqui, M. S., Francois, M., Hecker, J., Faunt, J., Fenech, M. F., & Leifert, W. R. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.001 · Cited by 20

Association between high levels of inflammatory markers and cognitive outcomes at 4 years of age: The Rhea mother-child cohort study, Crete, Greece

Kyriklaki, A., Margetaki, K., Kampouri, M., Koutra, K., Bitsios, P., Chalkiadaki, G., Dermitzaki, E., Venihaki, M., Sarri, K. O., Anousaki, D., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.010 · Cited by 20

Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration

Lai, M. M. Y., Sharman, M. J., Ames, D. J., Ellis, K. A., Cox, K. L., Hepworth, G., Desmond, P. M., Cyarto, E., Martins, R. N., Masters, C. L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190953 · Cited by 21

AMBAR, an Encouraging Alzheimer's Trial That Raises Questions

Loeffler, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00459 · Cited by 20

Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice

Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 19

Minocycline May Be Useful to Prevent/Treat Postoperative Cognitive Decline in Elderly Patients

Fan, L., Wang, T.-L., Xu, Y. C., Ma, Y. H., & Ye, W. G. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.010 · Cited by 19

Association Between Dental Implants and Cognitive Function in Community-dwelling Older Adults in Korea

Ki, S., Yun, J., Kim, J., & Lee, Y. (2019) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.19.163 · Cited by 19

Effect of renal impairment on cognitive function during a 3‐year follow up in elderly patients with type 2 diabetes: Association with microinflammation

Kawamura, T., Umemura, T., Umegaki, H., Imamine, R., Kawano, N., Tanaka, C., Kawai, M., Minatoguchi, M., Kusama, M., Kouchi, Y., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12190 · Cited by 19

Adenosine A2A Receptor and IL‐10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment

Arosio, B., Mastronardi, L., Gussago, C., Nicolini, P., Casè, A., Ziglioli, E., & Bergamaschini, L. C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/484021 · Cited by 20

Midlife interventions are critical in prevention, delay, or improvement of Alzheimer’s disease and vascular cognitive impairment and dementia

Gandy, S., Bartfai, T., Lees, G. V., & Sano, M. C. (2017) · F1000Research · doi:10.12688/f1000research.11140.1 · Cited by 17

Interleukin-1 Gene –511 CT Polymorphism and the Risk of Alzheimer’s Disease in a Polish Population

Klimkowicz‐Mrowiec, A., Marona, M., Wołkow, P. P., Maruszak, A., Styczyńska, M., Barcikowska, M., Żekanowski, C., Szczudlik, A., & Słowik, A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000259460 · Cited by 18

Increased Risk of Dementia Among Patients With Pulmonary Tuberculosis

Peng, Y., Chen, C., Su, C.-H., Muo, C., Chen, K.-F., Liao, W.-C., & Kao, C. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515577186 · Cited by 18

P1–209: Relations of serum inflammatory markers and monocyte production of cytokines to the risk for Alzheimer's disease: The Framingham study

Tan, Z. S., Seshadri, S. S., Beiser, A., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Vasan, R. S., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.586

P1‐210: Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment

Silvestri, A., Latini, A., Catucci, A. E., Caminiti, G., Pierangeli, D., Rosano, G. M. C., Fini, M., & Pagano, A. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.799

Levels of IL-6 in peripheral blood and cerebrospinal fluid of Alzheimer's disease: a meta-analysis

Xinyu Li1, W. W. (2023) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2023.050210

Detection of interleukin-1、interleukin-6 and tumor necrosis factor in serum in patients with Alzheimer disease

Zhongl, H. (2010) · Modern Practical Medicine · Cited by 1

APOE epsilon-4 allele and cytokine production in Alzheimer's disease

Olgiati, P., Politis, A., Malitas, P., Albani, D., Dusi, S., Polito, L., De Mauro, S., Zisaki, A., Piperi, C., Stamouli, E., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2344 · Cited by 35